|
Delayed
Nasdaq Stockholm
17:04:27 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.3545 SEK | -5.59% |
|
-17.47% | -57.84% |
| 10-21 | Alzinova Finalizes US Trial Sites for Mid-stage Alzheimer's Disease Vaccine Study | MT |
| 10-21 | Alzinova selects seven U.S. trial sites ahead of phase IIa study | FW |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -5.59% | -17.47% | -16.59% | -65.60% | -57.84% | -76.73% | -85.85% | -95.00% | -98.06% | 12.04M | |
| +0.34% | +1.12% | -11.06% | +12.96% | +57.65% | +34.75% | +61.06% | +3.54% | - | 64.38B | |
| -0.17% | +2.66% | -5.17% | +7.55% | +12.03% | +14.32% | +83.58% | +203.59% | +5,635.71% | 56.16B | |
| +0.84% | +2.31% | +12.38% | +13.36% | +20.19% | +15.76% | +107.51% | -15.30% | +246.04% | 54.16B | |
| -1.43% | -1.17% | +2.26% | +11.11% | +22.03% | +26.27% | +52.86% | +5.22% | +283.25% | 45.33B | |
| -0.48% | -2.80% | +1.72% | +13.55% | +22.30% | +18.01% | +117.99% | +3.87% | +1,010.13% | 42.25B | |
| +0.82% | +1.37% | -6.95% | +5.17% | +138.88% | +227.94% | +922.41% | +546.52% | - | 40.78B | |
| +0.29% | +43.61% | +62.06% | +105.91% | +87.32% | +106.41% | +90.71% | +32.35% | +239.62% | 33.8B | |
| -0.26% | -2.57% | +5.81% | +5.17% | +9.81% | +12.55% | +45.18% | +14.84% | +157.79% | 32.25B | |
| -1.29% | -2.88% | -20.64% | +17.67% | +41.48% | +21.60% | -11.92% | -60.11% | - | 23.57B | |
| +1.30% | -0.60% | -9.58% | -4.11% | -6.38% | -13.76% | -2.27% | -68.02% | - | 22.39B | |
| +15.06% | +17.39% | -3.49% | +8.21% | -35.88% | -33.16% | +367.29% | +270.12% | +724.15% | 24.37B | |
| -2.18% | +3.61% | +8.91% | +15.84% | +20.64% | +15.91% | +170.72% | +199.08% | +2,245.31% | 18.95B | |
| +0.57% | +10.73% | +27.08% | +60.18% | +88.54% | +108.77% | +117.92% | -16.18% | +394.87% | 17.95B | |
| +1.38% | +4.23% | +17.71% | +28.69% | +41.47% | +45.63% | +88.92% | -14.79% | +113.29% | 16.88B | |
| -0.12% | +1.36% | +12.87% | +19.65% | +51.04% | +67.89% | +227.72% | +207.76% | +508.46% | 16.4B | |
| +1.38% | +4.12% | +10.93% | +0.38% | - | - | - | - | - | 16.62B | |
| +0.62% | +16.21% | +26.49% | +20.93% | +18.25% | +29.85% | -8.43% | -24.86% | +168.28% | 16.14B | |
| +3.33% | +6.90% | +3.77% | +14.81% | +192.66% | +177.32% | +360.46% | +1,470.41% | +825.12% | 15.77B | |
| +1.61% | +21.99% | -5.74% | +87.34% | +31.82% | -12.38% | - | - | - | 14.05B | |
| Average | +0.73% | +5.68% | +5.64% | +18.94% | +39.79% | +41.42% | +150.33% | +147.95% | +889.57% | 28.61B | |
| Weighted average by Cap. | +0.82% | +5.08% | +4.91% | +20.15% | +42.50% | +46.40% | +163.83% | +125.86% | +1,259.67% |
- Stock Market
- Stocks
- ALZ Stock
- Sector Alzinova AB
Select your edition
All financial news and data tailored to specific country editions
